Screening for peripheral vascular disease: Why don't we do it?

International Journal of Clinical Practice

Volumn 56, Issue 6, 2002, Pages 412-413

  Bell, R E ^a   Taylor, P R ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ANGIOGRAPHY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EDITORIAL; EXERCISE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; MORTALITY; NON INVASIVE MEASUREMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STROKE;

AGED; ANKLE; BLOOD PRESSURE DETERMINATION; BRACHIAL ARTERY; CORONARY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PUBLIC HEALTH PRACTICE;

EID: 0036340150     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Peripheral arterial disease detection, awareness, and treatment in primary care
2. The prevalence of peripheral artery disease in a defined population
3. The ratio of ankle and arm arterial pressure as an independent predictor of mortality
4. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing
5. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in patients at increased risk of coronary heart disease death
6. Randomised trial of cholesterol lowering in 4444 patients with coronary artery disease: The Scandanavian Simvastatin Survival Study (4S)
7. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: A meta-analysis of individual patient data from randomised controlled trial
8. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
9. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetics. UKPDS 38
10. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
11. A randomised, blinded trial of clopidogril versus aspirin in patients at risk of ischaemic events (CAPRIE)